Clinical Trials Directory

Trials / Completed

CompletedNCT02983448

Noninvasive Neuromodulation to Reserve Diastolic Dysfunction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This is a 2x2 cross over pilot study using low level transcutaneous vagus nerve stimulation (LLTS) to reverse diastolic dysfunction in patients with diastolic dysfunction. All patients will receive 2 separate, 1-hour sequences, at least 1 day apart, of active and sham LLTS, but the sequence will be randomized. Patients will be randomly assigned (1:1) to active/sham or sham/active LLTS. LLTS will be performed using a transcutaneous electrical nerve stimulation (TENS) device with electrodes attached to the tragus of the ear, which is innervated by auricular branch of the vagus nerve. Echocardiography will be performed after 30 minutes of LLTS or sham stimulation to assess diastolic function. Five-minute ECGs will be obtained for HRV analysis every 15 minutes of stimulation (total of 4 recordings).

Conditions

Interventions

TypeNameDescription
DEVICEtranscutaneous vagus nerve stimulationAll patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized

Timeline

Start date
2016-12-01
Primary completion
2018-03-01
Completion
2018-04-01
First posted
2016-12-06
Last updated
2019-06-25
Results posted
2019-06-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02983448. Inclusion in this directory is not an endorsement.